Advertisement

Topics

Ariad's treatment for rare leukemias receives FDA approval

04:25 EST 1 Dec 2016 | SmartBrief

Ariad Pharmaceuticals has received approval and a label update from the FDA for Iclusig, or ponatinib, for use in patients wi -More

Original Article: Ariad's treatment for rare leukemias receives FDA approval

NEXT ARTICLE

More From BioPortfolio on "Ariad's treatment for rare leukemias receives FDA approval"

Quick Search
Advertisement